멸종된 동물을 되살리는 일이 더 이상 영화 속 이야기가 아니라는 사실, 알고 계셨나요? AI 멸종 복원 기술은 이미 수십억 달러 규모의 스타트업이 뛰어들 만큼 현실이 되었습니다. 오는 10월 13일부터 15일까지 샌프란시스코 모스콘 웨스트에서 열리는 TechCrunch Disrupt

AI and De-Extinction: Rewriting Extinction With Code

AI Quietly Takes Over Species Conservation Decisions

👽 Did Ancient Civilizations Possess the Keys to Molecular Resurrection? Ever wondered why the ancients were so obsessed with preserving the dead? It wasn't just a religious ritual—it was a biological mimicry of high-tech suspended animation. In this episode, we expose the shocking theory that early humans witnessed 'Sky Gods' entering metallic biostatic chambers and spent millennia trying to copy them using salt and linen. From the Inca Ice Maiden to the Egyptian Necropolis, we dive into how mummification secrets were actually attempts to create a biological time capsule for future genetic resurrection. We explore: - 🧬 Molecular Resurrection: Why modern DNA sequencing is finally fulfilling an ancient alien agenda. - 🚀 Cryo-Chambers of Osiris: The evidence that sarcophagi were modeled after extraterrestrial cryo-pods. - 💉 Ancient Bio-hacking: How Anunnaki medical knowledge and the divine origin of acupuncture reveal a lost 'bio-circuitry' of the human body. - 🌌 The Afterlife Paradox: Is the journey to the stars actually a hidden manual for interstellar travel? This isn't just history—it's the intersection of paleogenetics and CRISPR de-extinction. We're bridging the gap between prehistoric myth and futuristic cloning technology to ask: Are we finally 'unlocking' the dead as intended? Join the conversation and uncover the truth behind our celestial origins. ✨ Subscribe now to stay ahead of the narrative and share this episode with a fellow truth-seeker!  

On April 30, 2026, Colossal Biosciences, a Texas-based biotechnology and genetic engineering company, announced its intention to expand its de-extinction p

What happens when academics spar with a multibillion dollar corporation?

Colossal Biosciences, a de-extinction startup known for its efforts to resurrect extinct species like the dire wolf, is reportedly in discussions to raise new capital at a valuation between $20 billion and $30 billion. This follows its previous $10.2 billion valuation and marks significant growth over 16 months. The company has already begun generating revenue through contracts with the U.S. government and the UAE, which invested $60 million in 2025. Colossal has spun off three startups, including Breaking (plastic breakdown), Form Bio (computational biology), and Astromech (AI-driven predictive modeling). CEO Ben Lamm highlighted plans to commercialize artificial animal womb technology for human fertility applications, expected by 2027. The fundraising comes amid a boom in deep-tech sectors like longevity tech and alternative energy. While the company has not commented on the report, its advancements in genetic engineering and conservation tech position it as a key player in biotech innovation.

The recent news on so-called "de-extinction" inspired me to consider what true de-extinction would actually look like, especially for scientists who study the ecology and conservation of at-risk speci...

The move comes as the Trump administration is trying to weaken the act that’s meant to protect endangered species from going extinct in the first place.